Status:

COMPLETED

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Lead Sponsor:

GlaxoSmithKline

Conditions:

Cervical Intraepithelial Neoplasia

Papillomavirus Infection

Eligibility:

FEMALE

10-14 years

Phase:

PHASE3

Brief Summary

This protocol posting deals with objectives \& outcome measures of the extension phase up to Month 48. The objective of the extension study is to evaluate the long-term immunogenicity of the HPV 16/18...

Eligibility Criteria

Inclusion

  • A female who enrolled in the immunological subset of the 580299-013 study, received the three doses of vaccine/control according to the treatment allocation and completed the 580299-013 study.
  • Written informed assent obtained from the subject and written informed consent obtained from a parent or legally acceptable representative of the subject.

Exclusion

  • Concurrently participating in another clinical study, at any time during the study period, in which the subject has been or will be exposed to an investigational or a non-investigational product (pharmaceutical product or device).
  • Use of any investigational or non-registered product (drug or vaccine) or planned use during the study period.
  • Chronic administration of immunosuppressants or other immune-modifying drugs occurring less than 3 months prior to blood sampling.
  • Administration of immunoglobulins and/or any blood products within the 3 months preceding blood sampling.

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

1245 Patients enrolled

Trial Details

Trial ID

NCT00316706

Start Date

October 1 2005

End Date

January 1 2009

Last Update

September 18 2012

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

GSK Investigational Site

Bogotá, Colombia, 805

2

GSK Investigational Site

Bogotá, Colombia

3

GSK Investigational Site

Deggingen, Baden-Wurttemberg, Germany, 73326

4

GSK Investigational Site

Ettenheim, Baden-Wurttemberg, Germany, 77955